Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VCELthis companyVericel Corporation	$57.25	109.12×	5.14×	6.59×	60.08×	-143.2%	74.4%	4.0%	6.0%	4.7%	2.3%	1.4%	0.28×	-0.06×	7.1×	5.03×	0.0%	6	9.6	2	C+
ABEOAbeona Therapeutics Inc.	$2.80	3.93×	1.75×	47.95×	2.87×	-76.4%	73.7%	-1536.9%	1223.1%	44.7%	-44.0%	-30.2%	0.16×	-0.68×	-23.92×	6.93×	0.0%	2	-3.55	2	C
BVSBioventus Inc.	$10.63	21.88×	2.69×	0.87×	7.62×	-120.1%	67.3%	10.3%	4.0%	12.3%	10.8%	14.4%	1.69×	2.62×	2.21×	1.7×	0.0%	7	2.15	4	A-
IARTIntegra LifeSciences Holdings Corporation	$13.61	-1.85×	0.91×	0.58×	-8.46×	77.8%	51.7%	4.2%	-31.6%	-49.5%	1.9%	-4.7%	1.95×	-5.53×	0.79×	2.54×	0.0%	7	1.31	3	B
MDXGMiMedx Group, Inc.	$3.26	20.52×	3.9×	2.39×	10.33×	13.9%	82.6%	15.3%	11.6%	18.9%	16.7%	7.3%	0.09×	-1.73×	35.83×	4.32×	0.0%	4	6.57	2	C
Peer median	—	12.22×	2.22×	1.63×	5.24×	-31.3%	70.5%	7.2%	7.8%	15.6%	6.3%	1.3%	0.92×	-1.21×	1.5×	3.43×	0.0%	6	1.73	3	—